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Staphylococcus aureus is a pathogen that has been associated with nosocomial infections
since the preantibiotic era. Since the introduction of antibiotics in medical practice in the 1940’s,
methicillin-resistant S. aureus (MRSA) strains have been emerging in various parts of the world.
In view of the important role of the phagocytic system in the defense against this bacteria, we
decided to study phagocytosis by neutrophils and monocytes of an epidemic MRSA strain in São
Paulo, Brazil, in comparison with methicillin-sensitive strains. Complement system opsonins
are fundamental for efficient ingestion of the resistant and sensitive strains by both types of
phagocytes. We found no association of the opsonic requirement of the MRSA strain with the
multiresistance phenotype. On the other hand, the MRSA strain was found to be more resistant to
the effector mechanisms of neutrophils than both sensitive strains when opsonized with fresh
serum, despite the phagocytosis results. This fact suggests that the intracellular killing of S.
aureus is an additional parameter of bacterial virulence, but new approaches must be implemented
to study the interactions of this MRSA strain with phagocytes in order to investigate the possible
factors involved in its behavior in response to neutrophil effector mechanisms.
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Staphylococcus aureus is a pathogen that
contains biochemical machinery that enables it to
quickly colonize and invade its host through minor
breaks in the skin and mucous membranes, as well
as to protect itself against many of the host’s
defenses, thereby frequently reaching the
bloodstream [1]. This bacterium has persisted as
an important public health problem since the
preantibiotic era, when staphylococcal bacteremia
was frequently mortal for the affected patient [2].
Antibiotic use increased through the 1950’s and
resistance rapidly developed [1], producing strains
of S. aureus that were resistant to methicillin and
oxacillin (MRSA) [3,4].
Peripheral blood phagocytes participate in the
nonspecific defense against extracelullar bacteria. This
interaction between cell and bacterium is important to
eliminate the pathogen from blood or tissues.
Neutrophils and monocytes are cells that actively
participate in this process; they are able to kill these
bacteria by phagocytosis, with consequent lysosomal
degranulation and activation of oxidative metabolism.
There is much data concerning MRSA epidemiology,
but studies on host defense mechanisms against these
strains are rare. Some investigators have studied the
possible association of multiresistance phenotype and
resistance in the phagocytic system, but with
contradictory results [5-8].
In view of this situation, we decided to study the
phagocytosis and killing of an epidemic MRSA strain
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in Brazilian hospitals by normal human neutrophils and
monocytes.
Material and Methods
Human blood
Peripheral venous blood was collected from 57
healthy adult male blood donors from “Fundação Pró-
Sangue do Hemocentro de São Paulo” (aged 18-49
years).
Bacterial strains and culture conditions
The methicillin-resistant strain (MRSA) and a
methicillin-sensitive strain of S. aureus (MSSA) were
obtained from the Special Microbiology Laboratory
of the Division of Infectious Diseases (Federal
University of Sao Paulo). The MRSA strain had been
isolated from a patient at a Hospital in São Paulo city,
and it presented an epidemic pattern of chromosomal
DNA when analyzed by pulsed-field gel
electrophoresis, based on Sader et al. [9]. The MSSA
strain was collected from a nasal carrier at Sao Paulo
Hospital. Another methicillin-sensitive strain (CO -
Cowan I - ATCC 12598), previously used to
standardize the phagocytosis assay, was obtained from
the Culture Collection Department of the Adolfo Lutz
Institute. The strains were maintained lyophilized, and
were cultured in Mueller Hinton broth (Difco
Laboratories, Detroit, USA) at 37°C with shaking for
16 h for the phagocytosis assay. The MRSA strain was
resistant to oxacillin, penicillin, ampicillin, cefoperazone,
cefoxitin, ceftazidime, ceftriaxone, gentamicin,
tobramycin, ciprofloxacin, norfloxacin, and lincomycin,
and was sensitive to vancomycin, netilmycin, and
nitrofurantoin, presenting intermediate sensitivity to
rifampicin, according to the antibiogram method of
Bauer et al. [10]. The MSSA and CO strains were
sensitive to all antibiotics with the exception of
intermediate sensitivity to cefoperazone and
ceftazidime, and resistance to penicillin only in the
MSSA strain.
All three S. aureus strains were producers of DNase,
coagulase, fibrinogen binding protein, and protein A,
and none of them presented a capsule by the China ink
technique [11-15]. β-Lactamase production was
detected only in the MRSA and MSSA strains [16].
Bacterial opsonization
Bacteria of three strains were opsonized with a pool
of normal human sera (fresh sera - FS or inactivated
sera at 56°C for 30 minutes - IS) or unopsonized (without
serum - UN). In separate experiments, opsonization with
fresh serum from an agammaglobulinemic patient (AG)
was compared with FS. Fresh sera were kept at -70°C.
The levels of immunoglobulins and C3 complement
protein in FS and AG were determined (Table 1).
Bacteria were then incubated with 10% serum at 37°C
for 30 minutes, to a final concentration of 2 x 107 cfu/
mL in TC-199 medium buffered with 20 mM HEPES
(TC199/HEPES).
Leukocyte preparation
Leukocytes were separated from heparinized whole
blood by sedimentation with 4.5% Dextran T-500 at 37°C
for 30 minutes. The leukocyte-rich plasma was removed,
washed twice with Hanks’ balanced salt solution (HBSS)
by centrifugation at 160 g for 10 minutes, and resuspended
in TC199/HEPES at 2 X 106 phagocytes/mL.
Phagocytosis and bacterial killing
Phagocytosis and bacterial killing by neutrophils and
monocytes were assessed by a fluorochrome technique
[17, 18], using acridine orange staining to determine
living (green) and non-living (red/yellow) bacteria.
Phagocytosis index (PI), and percent killed bacteria
(%KB) were calculated as in Bellinati-Pires et al. [18].
Statistical analysis
Each parameter was analyzed by Multifactor
ANOVA (BMDP statistical software, Westwood, CA)
and by the Multiple Comparisons Test (Tukey’s Test).
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Table 1. Levels of immunoglobulins and C3 protein of the complement system in pools of fresh normal human
sera (FS) and in fresh serum from an agammaglobulinemic patient (AG)
Results
Levels of immunoglobulins and C3 protein of the
complement system in fresh sera used for
opsonization (Table 1)
Despite the low level of immunoglobulins in the AG
serum, the complement C3 was within the normal range.
Effect of bacterial opsonization, with fresh normal
human serum (FS) or aggamaglobulinemic serum (AG),
on the phagocytosis by neutrophils and monocytes
No differences were observed in the effects of
opsonization with FS versus AG on the ingestion
and killing of bacterial strains by phagocytes
(Table 2).
Comparison of the MRSA, MSSA and CO strains
after opsonization with fresh serum, inactivated
serum or unopsonized
It was evident that the CO strain was more
phagocytized by neutrophils or monocytes than other
strains. When fresh serum was used, the difference among
PI values was significant between CO and MRSA for
monocytes. However, when inactivated serum (IS) was
used, increased differences between CO and MRSA
or MSSA strains were observed in the PI values
obtained for both types of phagocytes (Figure 1).
Phagocytosis of MRSA by Human Phagocytes
Table 2. Comparison of normal serum and agammaglobulinemic serum in the phagocytosis of Staphylococcus
aureus strains
Phagocytosis of multidrug-resistant Staphylococcus aureus strain (MRSA), and two sensitive strains
(MSSA and CO), by neutrophils and monocytes after opsonization with a pool of fresh normal human
serum (FS) or serum from an agammaglobulinemic patient (AG). Results are reported as means ± SEM.
PI = phagocytosis index; %KB = percent killed bacteria.
Phagocytes Parameters CO MSSA MRSA
PI FS 8.69 ± 0.92 8.67 ± 0.55 7.30 ± 0.52
Neutrophils AG 7.93 ± 0.66 8.15 ± 0.87 7.15 ± 0.59
%KB FS 50.11 ± 4.27 39.05 ± 3.79 34.50 ± 4.14
AG 45.95 ± 4.69 37.27 ± 5.57 35.94 ± 5.14
PI FS 6.78 ± 0.74 6.29 ± 0.46 5.87 ± 0.34
Monocytes AG 6.94 ± 0.84 6.23 ± 0.49 6.00 ± 0.39
%KB FS 58.49 ± 6.08 46.35 ± 3.33 46.66 ± 6.43
AG 55.43 ± 4.75 52.01 ± 7.73 45.59 ± 6.35
Serum IgG (g/L) IgM (g/L) IgA (g/L) C3 (g/L)
FS 16.61 1.44 2.79 0.96
AG 4.25 ND ND 0.87
ND = not detected. Normal range for adult individuals: IgG = 7.10 - 15.20 g/L (Tmax kit); IgM
= 0.40 - 2.40 g/L (IAC kit); IgA = 0.90 - 3.10 g/L (IAC kit); C3 = 0.84 - 1.93 g/L (Tmax kit).
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Figure 1. Comparisons of Staphylococcus aureus Cowan I (CO), sensitive (MSSA) and multi-drug resistant
(MRSA) strains opsonized with a fresh or inactivated pool of human serum or unopsonized, with respect to
phagocytosis by normal human neutrophils (A) and monocytes (B). Results are reported as mean ± SEM
phagocytosis index (PI) (Multifactor ANOVA with repeated measures and Multiple Comparisons Test –    ,    =
p<0.05).
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Figure 2. Comparisons of Staphylococcus aureus Cowan I (CO), sensitive (MSSA) and multi-drug resistant
(MRSA) strains opsonized with a fresh or inactivated pool of human serum or unopsonized, with respect to
intracellular killing by normal human neutrophils (A) and monocytes (B). Results are reported as mean ± SEM
percent killed bacteria (%KB) (Multifactor ANOVA with repeated measures and Multiple Comparisons Test –
      ,    ,       = p<0.05).
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The MRSA strain was more resistant to killing by
neutrophils than the other two sensitive strains (CO
and MSSA), when opsonized with FS, and more
resistant to killing by neutrophils than MSSA when non-
opsonized (Figure 2).
Discussion
Since virulent staphylococci have been found to
survive the bactericidal action of neutrophils better than
avirulent strains [19,20], we explored the possible
relationship between expression of resistance to multiple
drugs by strains of MRSA and survival of these
organisms in neutrophils and monocytes. To answer
this question, we selected a multidrug-resistant MRSA
strain isolated from the intravenous catheter of a
hospitalized Brazilian patient and two strains sensitive
to multiple antibiotics (CO and MSSA strains).
In view of the high mortality caused by nosocomial
infections with MRSA, we thought it important to verify
whether, in addition to antibiotic resistance, other
intrinsic bacterial factors could influence their virulence
to the host. We examined the presence of some
bacterial products, such as DNase, coagulase,
fibrinogen-binding protein (FgBP), protein A (PA) and
a capsule, which are among S. aureus virulence factors
used in phagocytic system escape mechanisms [21-
23]. The strains produced all the virulence factors that
were tested, and we did not detect expression of a
capsule by the China ink technique. These results may
facilitate comparisons among strains in phagocytosis
assays because they can usually be compared only on
the basis of their antibiotic resistance polarity. Other
authors also observed that MRSA strains were
producers of coagulase [5,24] and FgBP [24] on
independent multiresistance phenotype. We noted that
the China ink technique was not sensitive enough to
detect microcapsule expression or the absence of a
capsule by the strains. Odierno et al. [15] also noted a
lower sensitivity of this technique when they compared
various techniques, although the China ink technique
continues to be used because it permits direct results.
As reported in the literature, microencapsulated strains
are the most commonly encountered types of strains
among S. aureus clinical isolates in humans and animals
[25]. PA, detected by immunoblotting and radial double
immunodiffusion, was present in all three strains.
Although a possible loss of resistance phenotype to
methicillin/oxacillin antibiotics by S. aureus strains
cultured at 37°C in vitro has been reported [26], our
MRSA strain maintained its resistance after repeated
cultivation at 37°C, as evaluated by the antibiogram or
E-Test (AB Biodisk, Sweden), even after 10 repeated
cultures (data not shown). Our findings are in agreement
with Peacok et al. [6] who also observed maintenance
of resistance phenotype in a MRSA strain after
incubation at 30, 35, and 37°C. Culture conditions such
as broth or solid medium, medium composition, and
growth period, are also thought to influence quantitative
or qualitative expression of bacterial products [27-29].
This investigation was necessary because our strains
were maintained in simple agar at 37°C for one month
for the phagocytosis assay.
We applied the fluorochromic technique to evaluate
the phagocytosis of each strain by normal human
neutrophils and monocytes in order to determine the
influence of serum opsonins on the strains. We observed
that both types of phagocytes gave a diminished
phagocytosis index (PI) for the three strains after
treatment with inactivated serum (IS) or when serum
was absent (UN), compared to treatment with a pool
of fresh human serum (FS) (data not shown – n=18).
These results confirm that the staphylococcal strains
studied in this work were dependent on opsonization
by heat-labile serum opsonins in order to be efficiently
internalized by phagocytes. In the same set of
experiments, we noted that only the killing by neutrophils
of the CO strain, opsonized with IS or unopsonized,
was affected. Actually, Gordon et al. [30,31], studying
the phagocytosis of the S. aureus Cowan I strain and
Escherichia coli, observed that ingestion via iC3b
receptors augmented the neutrophil-mediated
intracellular mortality of these bacteria.
When comparing bacterial opsonization with FS and
fresh serum from an agammaglobulinemic patient (AG),
we found no differences between treatments in the
ingestion or killing of the three strains by the two types
Phagocytosis of MRSA by Human Phagocytes
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of phagocytes. Considering that IgG levels in AG serum
were 25% of FS IgG levels, with undetectable IgM
and IgA levels and C3 protein within the normal range
(Table 1), we conclude that specific immunoglobulins
(Ig) had no effect on S. aureus ingestion or killing by
phagocytes (Table 2). These data also confirmed the
positive influence of heat-labile serum opsonins. In
examination of the anti-phagocytic role of PA in the S.
aureus evasion mechanisms, the results did not reveal
any alterations in the phagocytic function of neutrophils
and monocytes against any of the three bacterial strains,
all of them PA producers, despite bacterial opsonization
with normal or agammaglobulinemic serum. However,
we can not rule out a possible anti-phagocytic activity
of this protein in a systemic infection with S. aureus
(bacteremia/septicemia) when a considerable increase
in Ig levels occurs. In deep infections, in addition to Ig
hyper-production, increased bacterial propagation and
PA discharge occur, which may block the Fc IgG
portions, inhibiting opsonization and phagocytosis via
Fc receptors. Furthermore, free PA may binds to
specific Igs produced during infection, inactivating the
complement system by the classical pathway [23].
After evaluating the influence of complement system
opsonins on the ingestion and killing of each strain
separately, we performed a comparative study of three
S. aureus strains in the same phagocytosis experiment.
We found that the phagocytosis index (PI) obtained
with the MRSA strain was lower than that obtained
with the CO strain but similar to that obtained for the
MSSA strain, both for neutrophils and monocytes,
independent on the kind of opsonization (Figure 1).
Thus, it does not seem that reduced ingestion of MRSA
is associated with the multiresistance phenotype, at least
under these experimental conditions.
In agreement with our data, Peacock et al. [6] did
not observe any difference in the ingestion of a multi-
drug resistant MRSA strain and 3 strains sensitive to
various antibiotics by human neutrophils, after 15, 30,
60 and 120 minutes of phagocytosis in the presence of
FS. They found that more than 99% of the bacteria
were ingested after 60 minutes of incubation. Jordens
et al. [5] also did not detect any difference in ingestion
by human neutrophils of 7 multidrug-resistant MRSA
strains, 5 strains resistant only to penicillin and 2 sensitive
strains opsonized with FS, after 30 minutes of
phagocytosis.
Concerning killing by phagocytes, we observed that
the MRSA strain had reduced values of %KB in
neutrophils when compared to both sensitive strains
after FS opsonization (Figure 2). This was a unique
situation, in which the MRSA strain differed from
sensitive strains for the same parameter. With respect
to the CO strain, which is dependent on heat-labile
serum opsonin activity for efficient killing by neutrophils,
we think that serum inactivation or its absence in the
phagocytic assay abolished the factors that cause
differences between the CO and MRSA strains.
Based on in vitro phagocytosis data for the MRSA
strain opsonized with FS, Vaudaux & Waldvogel [7]
reported that 12 multi-drug resistant MRSA strains
survived better within neutrophils than a sensitive strain
after 30 and 60 minutes of incubation. However, they
did not observe any correlation between level of
methicillin resistance and strain survival in these cells.
On the other hand, in 1979, when these same
investigators decided to study the mortality of 8
MRSA strains in comparison with 2 sensitive strains
after 1, 3, 5 and 24 hours of incubation with
neutrophils [8], they did not confirm the differences
observed in their previous study. Thus, they concluded
that expression of methicillin resistance did not
influence bacterial survival within neutrophils in their
second study. Similarly, Peacock et al. [6] did not
observe any difference in intracellular mortality of a
multi-drug resistant MRSA strain in relation to 3
sensitive strains after 15, 30, 60 and 120 minutes of
incubation with neutrophils, and observed that more
than 93% of bacteria were ingested after 60 minutes
of incubation. All of the above data were obtained by
counting the number of S. aureus colony forming units
by the pour plate technique, which differs from our
microscopic methodology. Considering
methodological variances and lack of data about
interactions of multidrug-resistant staphylococci with
the phagocytic system, it would be premature to
attempt to compare our data with those obtained in
these cited studies.
Phagocytosis of MRSA by Human Phagocytes
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Peacock at al. [6] performed studies on mice
inoculated intraperitoneally with a MRSA or 3
sensitive strains (MSSA1, MSSA2 and Wood 46)
to establish the LD50. They did not observe any
difference between MRSA and MSSA1 and
MSSA2, but the MRSA strain was considered to
be less virulent than Wood 46. However, when they
compared strains by means of intravenous injection
of staphylococci in mice they showed that MRSA
was more virulent than MSSA1 and Wood 46 and
less virulent than the MSSA2 strain. Cutler [24], in
a study of a MRSA strain and 3 variants of this strain
whose resistance to some antibiotics was suppressed
by culture at 42°C for 7 days, observed greater
virulence for MRSA than for the other strains in mice
and guinea-pigs subcutaneously injected with these
bacteria. These contradictory data demonstrate the
great difficulty in establishing parameters for
evaluating staphylococcal virulence.
Some researchers have evaluated the association
between resistance to antibiotics and S. aureus cell
wall features. Cutler [24] suggested that alterations
in staphylococcal cell walls related to the
multiresistance phenotype could affect S. aureus
virulence. Penicillin-resistant staphylococci have a
greater cell wall lipid content and different
immunoelectrophoretic mobilities than penicillin-
sensitive variants of the same strains [32]; penicillin
resistance and cell wall thickness could be associated
[33] and gentamicin resistance may produce
morphological changes in the cell wall [34]. It should
be emphasized that strains resistant to methicillin/
oxacillin have penicillin-binding proteins (PBPs) in
their cell walls (named PBP2a), different from the
PBPs of methicillin/oxacillin sensitive strains. These
proteins, encoded by the chromosomal mecA gene,
are responsible for the formation of S. aureus cell
wall peptidoglycan chains, and are also targets for
antibiotics such as penicillin [9,35,36]. Considering
that these altered PBP2a continue to be accountable
for cell wall structure and taking into account the above
data about the cell wall, we can hypothesize that
resistant strains have a morphology that confers
greater protection against destruction by lysosomal
enzymes or by oxidative metabolism products of
phagocytes. It would be interesting to investigate the
cell wall structure of our MRSA strain more
accurately, since it is also resistant to penicillin and
gentamicin, among other antibiotics, facts that might
involve cell wall alterations.
We would like to emphasize some behavioral
differences between neutrophils and monocytes with
respect to their interactions with the S. aureus strains
evaluated in this work. Although neutrophils
phagocytized many more bacteria than monocytes, the
latter cells had a staphylococcidal capacity similar to
or higher than that of the neutrophils (p<0.05). These
observations raise questions about statements that
monocytes are less efficient than neutrophils to eradicate
extracellular pathogens [37], such as staphylococci. We
also emphasize that, due to lack of data on phagocytosis
and killing of MRSA by monocytes, our results could
be useful as a starting point for future investigations
about phagocytic functions against strains with different
resistance phenotypes.
We conclude that, under the present experimental
conditions, complement system opsonins are
fundamental for the efficient ingestion of these three
bacterial strains by human neutrophils and monocytes.
Although the mortality of the MRSA strain was only
lower than that of the sensitive strains in the presence
of neutrophils after opsonization with FS, we could not
demonstrate any correlation of the multiresistance
phenotype with MRSA survival in response to
phagocyte effector mechanisms.
On this basis, our experimental protocol can be
utilized as a model for evaluating these bacteria with
primed leukocytes, mimicking a situation of
staphylococcal infection. We believe that this study
provides new approaches to the evaluation of MRSA
pathogenicity and its interaction with the human
phagocytic system.
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